Stephen MacMahon AO's Publications

About Stephen MacMahon AO's Publications

Founding Director, The George Institute for Global Health
  • Professor of Cardiovascular Medicine, Faculty of Medicine, UNSW Sydney
  • Chair of Global Health, Faculty of Medicine, Imperial College of London

  • Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]

    Cardiovascular Diabetology Date published:

  • Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease

    European Heart Journal Date published:

  • Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease

    Circulation Date published:

  • Blood pressure and the burden of coronary heart disease

    Coronary Heart Disease Epidemiology Date published:

  • Effects of Different Blood Pressure-Lowering Regimens on Major Cardiovascular Events in Individuals With and Without Diabetes Mellitus

    Archives of Internal Medicine Date published:

  • ADVANCE-Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline

    Diabetic Medicine Date published:

  • Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months

    The Lancet Date published:

  • Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region

    International Journal of Epidemiology Date published:

  • A Comparison of Lipid Variables as Predictors of Cardiovascular Disease in the Asia Pacific Region

    Annals of Epidemiology Date published:

  • Hypertension-time to move on

    The Lancet Date published:

  • Prediction of Heart Failure by Amino Terminal-pro-B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease

    Hypertension Date published:

  • Perindopril-based blood pressure lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or TIA

    Date published:

  • Effects of long term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomized controlled trial

    pan class="rg-author">Suranyi MG, 2005, 'Effects of long term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomized controlled trial', Lancet Date published:

  • Perindopril-Based Blood Pressure-Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack

    Stroke Date published:

  • The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

    Cardiovascular Diabetology Date published:

  • The PROGRESS trial three years later: time for more action, less distraction

    BMJ Date published: